We found that the promoter methylation level of USP5 decreased in most cancers, including BLCA, BRCA, CHOL, COAD, ESCA, HNSC, LIHC, LUAD, LUSC, PAAD, PRAD, READ and UCEC (Fig. 9A–M). This evidence concerns the gene USP5 and cancer.